GL1X · GenesisL1 explorer

MolNFT v1 · #159788 · protein

Structure of spastin aaa domain (T692A mutant) in complex with a diaminotriazole-based inhibitor (crystal form B)

6P14: “Structure of spastin aaa domain (T692A mutant) in complex with a diaminotriazole-based inhibitor (crystal…”. X-ray diffraction, 2 ligands (NKY, SO4), 4 pockets (best druggability 0.56). MolNFT v1 #159788 on GenesisL1: 3D structure…

PDB
6P14
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spastin
EC
5.6.1.1
UniProt
Q8I0P1
Ligands
NKY, SO4
Pockets
4 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 55% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpastin (EC 5.6.1.1)protein26555% helix, 10% strandQ8I0P1

Ligands and binding sites

  • NKY · 3-{[5-amino-1-(2-fluoro-6-methoxybenzene-1-carbonyl)-1H-1,2,4-triazol-3-yl]amino}-N-methylbenzamide · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · 2 copies · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1780.560.8718empty
21530.520.7927empty
31830.510.7726MPD, NKY
4720.360.7712empty

Compared structures

  • 6P14 · Structure of spastin AAA domain (T692A mutant) in complex with a diaminotriazole-based… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8I0P1 · AlphaFold monomer V2.0 prediction for spastin (Q8I0P1) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.